Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA

Lopes, R.D. ✉; Granger, C.B.; Wojdyla, D.M.; McIntyre, W.F.; Alings, M.; Mani, T.; Ramasundarahettige, C.; Rivard, L.; Atar, D.; Birnie, D.H.; Boriani, G.; Amit, G.; Leong-Sit, P.; Rinne, C.; Duray, G.Z. [Duray, Gábor Zoltán (Kardiológia), author] Cardiovascular Center (SU / FM / C); Gold, M.R.; Hohnloser, S.H.; Kutyifa, V. [Kutyifa, Valentina (Orvostudományok), author]; Benezet-Mazuecos, J.; Cosedis, Nielsen J.; Sticherling, C.; Benz, A.P.; Linde, C.; Kautzner, J.; Mabo, P.; Mairesse, G.H.; Connolly, S.J.; Healey, J.S.

English Article (Journal Article) Scientific
  • SJR Scopus - Cardiology and Cardiovascular Medicine: D1
Identifiers
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-13 13:37